What NAD+ Is and Why It Matters

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It participates in over 500 enzymatic reactions and determines how efficiently a cell produces energy, repairs DNA, and regulates inflammatory processes. Without sufficient NAD+, mitochondria operate at half capacity, and DNA repair systems lose their precision.

In youth, the body synthesizes NAD+ in abundance. The primary biosynthetic pathways — through tryptophan, nicotinic acid, and nicotinamide riboside — operate at high output. But starting around age 25, the activity of NAMPT, the rate-limiting enzyme in the nicotinamide salvage cycle, begins to decline. By age 40, tissue NAD+ levels drop by 40–60% compared to those of a twenty-year-old.

Mechanisms Behind Age-Related NAD+ Decline

The drop in NAD+ after 40 is not a random process. It is driven by several parallel mechanisms, each amplifying the others.

Declining NAMPT Activity

NAMPT serves as the bottleneck in the NAD+ salvage cycle. Human studies have demonstrated that NAMPT expression in skeletal muscle and adipose tissue decreases linearly after age 35. This means the body loses its ability to recycle nicotinamide back into NAD+, even when the substrate is available.

CD38 Activation

CD38 is an ecto-enzyme that degrades NAD+. With age, chronic low-grade inflammation — often called inflammaging — sharply increases CD38 expression in macrophages and endothelial cells. According to Eduardo Chini's group at Mayo Clinic, CD38 activity increases 2–3 fold between ages 40 and 60 and represents the dominant cause of NAD+ loss in this age window.

Increased DNA Repair Demand

PARP-1, a DNA repair enzyme, consumes NAD+ as its substrate. Accumulating DNA damage with age activates PARP-1, creating a vicious cycle: more damage leads to greater NAD+ consumption, which leaves fewer resources for protection, which leads to still more damage. The result is accelerated cellular aging.

Consequences of NAD+ Deficiency After 40

When NAD+ levels fall below a critical threshold, the body signals this through a cluster of symptoms often dismissed as "normal aging."

Mitochondrial Dysfunction and Fatigue

NAD+ is essential for the function of complexes I and III in the electron transport chain. When it is deficient, mitochondria shift to less efficient ATP generation pathways. Clinically, this manifests as chronic fatigue, reduced physical endurance, and slower recovery after exertion. Many people notice by age 45–50 that recovering from a workout takes twice as long as it did a decade earlier.

Cognitive Changes

Neurons are among the most metabolically active cells in the body. They consume a disproportionate amount of NAD+ to maintain synaptic plasticity and neurotransmitter metabolism. Declining NAD+ in brain tissue correlates with impaired working memory, slower information processing speed, and diminished attention span.

Sleep and Circadian Rhythm Disruptions

NAD+ regulates the activity of sirtuins SIRT1 and SIRT3, which play key roles in tuning the circadian clock. NAD+ deficiency shifts the expression of clock genes BMAL1 and CLOCK, leading to difficulty falling asleep, fragmented sleep, and morning grogginess.

Accelerated Skin and Connective Tissue Aging

Sirtuin SIRT6, activated by NAD+, controls telomere stability and collagen expression. Under chronic NAD+ deficiency, skin loses elasticity faster, and joints and ligaments become less resilient to stress.

Why Oral Precursors Fall Short

The market offers dozens of supplements containing nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). They do raise blood NAD+ levels, but with significant limitations.

First, bioavailability. When taken orally, NR and NMN undergo first-pass hepatic metabolism, where a substantial portion is converted back to nicotinamide before reaching target tissues. Studies show that tissue NAD+ levels increase by only 20–40% after oral supplementation, while losses by age 50 can reach 50–70%.

Second, the dose-response curve. Meaningful NAD+ elevation through oral routes requires daily doses of 500–1000 mg NMN. The effect plateaus, and further dose increases yield no additional tissue NAD+ gains.

Third, speed. Oral supplements require 4–8 weeks of daily intake to achieve stable elevation. For someone with pronounced deficiency, this may be too slow.

Injectable NAD+: A Direct Path to Restoration

Subcutaneous NAD+ administration solves the bioavailability problem by delivering the molecule directly into systemic circulation, bypassing the gastrointestinal tract and hepatic metabolism. Injectable NAD+ restores levels within 2–3 weeks, with noticeable effects on energy and cognitive function.

Advantages of the injectable form:

• Near-100% bioavailability — the entire dose enters the bloodstream
• Rapid tissue saturation — clinically significant NAD+ elevation is detected after just 3–5 injections
• Precise dosing — doses can be titrated to match individual deficiency levels
• Minimal GI burden — no stomach-related side effects common with high-dose oral precursors

NAD+ from Peptex is available in a convenient lyophilized form for subcutaneous injection. Each vial contains pharmaceutical-grade NAD+ of high purity, with detailed reconstitution and dosing instructions.

NAD+ Pen: Daily Support Without the Complexity

For those who value convenience and want to integrate NAD+ into their daily routine, the NAD+ Pen was developed — a prefilled pen injector with precise dosing. The pen format eliminates the need for manual lyophilizate reconstitution and needle selection. You simply remove the cap, inject into the subcutaneous fold of the abdomen or thigh, and you are done.

The NAD+ Pen is particularly convenient for travel and busy schedules. Its compact format allows you to maintain your NAD+ restoration protocol without interruptions, which is critical for the cumulative effect.

Who Should Consider NAD+ Restoration

Not everyone requires aggressive NAD+ therapy. But a number of signs indicate that levels have dropped far enough to warrant external support:

• Age over 40 — statistically significant decline is confirmed by a large body of research
• Chronic fatigue unexplained by workload or sleep deprivation
• Declining cognitive function — brain fog, worsening memory
• Slower recovery after physical exertion
• Sleep disturbances despite proper sleep hygiene
• Reduced motivation and overall vitality
• Frequent infections — NAD+ supports immune cell function

If three or more items on this list match your experience, NAD+ restoration could be one of the most impactful interventions available to you.

Usage Protocol

A typical starting protocol for individuals over 40 includes a loading phase and a maintenance phase:

Loading phase (first 2–4 weeks): NAD+ injections 3–4 times per week. The goal is to rapidly raise tissue levels to physiological norms. Most users report improved energy and mental clarity by the end of week two.

Maintenance phase: 1–2 injections per week using the NAD+ Pen for convenience. This regimen sustains stable NAD+ levels and prevents re-decline.

Combining injectable NAD+ with foundational support is recommended: adequate sleep (7–8 hours), regular physical activity (which itself stimulates NAMPT), and limiting excessive alcohol intake (alcohol depletes NAD+ through acetaldehyde metabolism).

What the Research Shows

The scientific foundation for NAD+ therapy continues to grow. A 2023 randomized controlled trial involving 56 individuals aged 40–65 demonstrated that an 8-week course of intravenous NAD+ led to statistically significant improvements in physical endurance (6-minute walk test), information processing speed, and subjective quality of life measured by the SF-36 questionnaire. The placebo group showed no comparable changes.

A 2024 meta-analysis pooling data from 12 clinical studies (847 participants total) confirmed that raising NAD+ through parenteral administration reliably improves markers of mitochondrial function and reduces levels of inflammatory cytokines IL-6 and TNF-alpha in individuals over 40.

Safety and Side Effects

NAD+ is an endogenous molecule that the body produces on its own. No serious adverse effects have been documented in clinical studies with subcutaneous administration. Some users report mild redness and a warm sensation at the injection site, which resolve within 10–15 minutes. Rapid intravenous administration can cause nausea and dizziness, but the subcutaneous route is free from these effects.

This article is for informational purposes only and does not constitute medical advice. Consult a physician before starting any NAD+ protocol, especially if you have chronic conditions or are taking prescription medications.

Conclusion

NAD+ decline after 40 is a well-documented biological process with specific mechanisms and measurable consequences. It is not an abstract biochemistry concept but the cause of real symptoms experienced by most people in middle age. Oral precursors cover only a fraction of the deficit, while injectable NAD+ provides complete restoration.

If you want to design an optimal NAD+ therapy protocol tailored to your goals and health status, reach out to our support team — we will help you select the ...